Radiofrequency Ablation Devices Market Size, Share Global Analysis Report, 2022 – 2030

Industry Insights

[230+ Pages Report]  According to the report published by Facts and Factors, the global radiofrequency ablation devices market size was worth around USD 3.59 billion in 2021 and is predicted to grow to around USD 10.21 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11% between 2022 and 2030. The report analyzes the global radiofrequency ablation devices market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the radiofrequency ablation devices market.

Market Overview

Radiofrequency ablation (RFA) is a medical procedure that is used to destroy tissue using heat energy. The method is used widely in the healthcare sector for pain management. During the procedure, radio waves are used to produce a current that leads to the heating of a certain area of the nerve tissue. The section where the heat is directed gets destroyed which means that the affected area is unable to send pain signals to the brain. RFA processes have known positive responses as they can help patients get rid of lasting chronic pain due to various medical conditions.

RFA devices have to be manufactured with complete accuracy as any defect can lead to serious harm to the patient. Radiofrequency ablation is a minimally invasive method that can help in shrinking the size of nodules, tumors, and other growth in the body. With the help of curated devices especially for conducting RFA procedures, the medical community has been able to expand its services in treating medical conditions that were earlier limited due to a lack of accurate treatment methods.

Key Insights

• As per the analysis shared by our research analyst, the global radiofrequency ablation devices market is estimated to grow annually at a CAGR of around 11% over the forecast period (2022-2030)
• In terms of revenue, the global radiofrequency ablation devices market size was valued at around USD 3.59 billion in 2021 and is projected to reach USD 10.21 billion, by 2030.
• The market is projected to grow at a significant rate due to the growing demand for pain management in the healthcare industry
• Based on type segmentation, bipolar radiofrequency ablation was predicted to show maximum market share in the year 2021
• Based on application segmentation, surgical oncology was the leading application in 2021
• On the basis of region, North America was the leading revenue generator in 2021

Growth Drivers

• Growing demand for pain management to drive market growth

The global radiofrequency ablation devices market is projected to grow owing to the increasing demand for pain management treatments due to the increasing number of medical patients affected by different conditions. RPA is one of the most preferred ways of managing pain concerns in patients who have long suffered from it. The process is used in the treatment of lower back or neck pain as well as pain induced by the worsening conditions of arthritis joints that could not be treated with any other method. RFA is carried out for various purposes including pain reduction or completely stopping it in certain cases. It can also be carried out to improve bodily functions or reduce the number of pain medications administered to the patient. In situations where surgeries cannot be conducted for any reason, the RFA technique can be used to delay the operation.

Since the procedure does not take a long time, the time duration can range from 15 minutes to 2 hrs, it is easy to conduct the process in case of long-duration surgeries. The recovery time of this process is also less which means that RFA is extremely patient-friendly and causes minimum discomfort. These are some of the few reasons why the demand for RFA procedures is increasing leading to high demand for the associated devices.

Restraints

• Minor side-effects to restrict market expansion

Some patients who have undergone the medical treatment experience mild swelling or numbness in the area the procedure was carried out on. Although these side effects subside in a few hours, the patient may register slight discomfort during the period which could restrict market expansion. Another, rare but possible and serious side effect could be bleeding in the section where the probe was inserted. The chances of such events are relatively low but not nil.

Opportunities

• Growing product innovation to provide growth opportunities

The global market is anticipated to register high growth opportunities due to the increasing investments in the development of new and better RFA devices as the demand for the procedures has increased rapidly in the last couple of years. For instance, in 2012, the Korean Society of Thyroid Radiology (KSThR) launched a thyroid-dedicated RFA device which has since then gained extreme popularity in the treatment of thyroid patients. Increasing product awareness and technique could further propel the demand for the technique and devices used in the process.

Challenges

• Postoperative complications to act as a major challenge

In a recent study published on the National Library of Medicine portal, cases were examined to understand the impact of RFA during the treatment of ductal pancreatic carcinoma. After analyzing the results, it was concluded that the majority of the postoperative complications were related to massive bleeding, septic shock, pancreatic fistulas, and portal thrombosis.

The concerns were also related to the palliative surgery in case double or single bypass surgery was carried out. These factors currently pose a major challenge for the global market players since in certain situations such complications can take serious turns putting the patient’s life in danger.

Segmentation Analysis

The global radiofrequency ablation devices market is segmented based on application, type, product, end-user, and region

Based on application, the global market divisions are cardiology & cardiac rhythm management, surgical oncology, and gynecology. In 2021, the highest growth was registered in the surgical oncology segment due to the growing use of the RFA technique to eliminate and eradicate cancerous tissues in the patient's body. As per official statistics, more than 1 million biopsies are conducted annually with the help of fine-needle instruments in the radiofrequency ablation processes. As the infrastructure for cancer treatment and detection grows globally, the demand for RFA devices is projected to generate higher revenue.

Based on type, the global market segments are bipolar radiofrequency ablation and unipolar radiofrequency ablation. Bipolar devices are used extensively to treat thyroid patients as these equipment are known to be effective during thyroid surgeries.

For instance, bipolar cautery forceps are time-saving, extremely safe, and simple to use. They are also equally effective as compared to higher-priced instruments like an ultrasonic scalpel. Usually, a catheter electrode in the RFA device delivers a high-frequency alternating current which is around 500 kHz between the tip and the indifferent electrode.

Recent Developments:

• In November 2022, Abbott, an American multinational medical device company, announced that it will launch the IonicRF Generator in the US market. It is an RFA device and received the necessary approval from the US Food and Drugs Administration authority a few months before the launch
• In October 2022, Biosense Webster, a part of the Jhonson & Jhonson Group, launched a new RFA catheter in the European market. The device is called the HELIOSTAR Balloon Ablation Catheter

Report Scope

Regional Analysis

• North America to lead the market growth

The global radiofrequency ablation devices market is projected to register the highest growth in North America owing to the high product and treatment awareness in the medical communities of the US and Canada. The extremely advanced healthcare and research infrastructure allow the players in the market to constantly invest in product innovation which is a major reason why RFA devices in the regional economies have found wide applications across medical issues. 

In recent times, the US FDA approvals have increased drastically to meet the growing demand in the economy. For instance, in 2017, the agency approved the use of COOLIEF Cooled Radiofrequency (Cooled RF) thermal treatment. It is used for the treatment of mild to severe knee pain complaints arising due to osteoarthritis. Currently, it is one of the few treatment plans that completely cure knee pain.

Competitive Analysis

• Sutter Medizintechnik Gmbh 
• AtriCure 
• C. R. Bard 
• Inomed Medizintechnik GmbH 
• Epimed International 
• Arthrex

The global radiofrequency ablation devices market is segmented as follows:

By Application Segment Analysis

• Cardiology & Cardiac Rhythm Management
• Surgical Oncology
• Cosmetology
• Gynecology

By Type Segment Analysis

• Bipolar Radiofrequency Ablation
• Unipolar Radiofrequency Ablation

By Product Segment Analysis 

• Disposables
• RF Generators
• Reusables

By End-User Segment Analysis

• Ambulatory Surgical Centers
• Hospitals
• Others

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America